4,169
edits
Changes
HAEM5:Volunteer Assignments and Opportunities (view source)
Revision as of 15:37, 23 December 2023
, 15:37, 23 December 2023no edit summary
|
|
|
|
|Lymphoplasmacytic Lymphoma + Waldenstrom Macroglobulinemia
|(1) Lymphoplasmacytic Lymphoma + (2) Waldenstrom Macroglobulinemia
|Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and *Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
|(1 and 2) Kapitolina Semenova, MD, Jack Reid, MD, Fabiola Quintero-Rivera, MD Departments of Pathology, Laboratory Medicine, and Pediatrics, Division of Genetic and Genomic Medicine, University of California, Irvine (UCI)
|Complete
|Complete
|4/12/2023 by FQR
|4/12/2023 by FQR
|
|
|Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity
|Author also needs to correlate with 4th edition disease "Testicular Follicular Lymphoma", which is no longer a separate entity
|Follicular Lymphoma + Testicular Follicular Lymphoma
|(1) Follicular Lymphoma + (2) Testicular Follicular Lymphoma
|Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
|(1 and 2) Ruthann Pfau, PhD, FACMG, Nationwide Children's Hospital Rachel D. Burnside, PhD, MBA, FACMG, University of Florida
|Pending
|Pending
|
|
|-
|-
|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| ||
|[[HAEM5:Primary large B-cell lymphoma of immune-privileged sites|Primary large B-cell lymphoma of immune-privileged sites]]||Disease|| || || || || ||GC|| ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified + Primary Diffuse Large B-cell Lymphoma of the CNS
|(1) Diffuse Large B-cell Lymphoma, Not Otherwise Specified + (2) Primary Diffuse Large B-cell Lymphoma of the CNS
|Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital
|(1) Ashwini Yenamandra, PhD FACMG, Vanderbilt University Medical Center + (2) Laveniya Satgunaseelan, FRCPA, Department of Neuropathology, Royal Prince Alfred Hospital
|Pending + Complete
|(1) Pending + (2) Complete
|Not ready + 03/28/22
|(1) Not ready + (2) 03/28/22
|For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022
|For "Diffuse Large B-cell Lymphoma, Not Otherwise Specified" page from Ash, Greg requested to update 14022022
|-
|-
|-
|-
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| ||
|Nodular lymphocyte predominant Hodgkin lymphoma||Disease|| || || || || ||GC|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Cold agglutinin disease
|Cold agglutinin disease